‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
30
00:00:00
/ 00:19:25
30